Corient Private Wealth LLC Cuts Stake in Sanofi $SNY

Corient Private Wealth LLC lessened its stake in shares of Sanofi (NASDAQ:SNY) by 14.6% in the 4th quarter, Holdings Channel reports. The firm owned 79,716 shares of the company’s stock after selling 13,615 shares during the period. Corient Private Wealth LLC’s holdings in Sanofi were worth $3,863,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of SNY. Flagship Harbor Advisors LLC purchased a new stake in Sanofi during the 4th quarter worth approximately $25,000. Measured Wealth Private Client Group LLC purchased a new stake in shares of Sanofi during the third quarter worth approximately $29,000. Palisade Asset Management LLC purchased a new stake in shares of Sanofi during the third quarter worth approximately $30,000. Annis Gardner Whiting Capital Advisors LLC raised its stake in Sanofi by 544.4% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 696 shares of the company’s stock valued at $34,000 after purchasing an additional 588 shares during the last quarter. Finally, Larson Financial Group LLC raised its stake in Sanofi by 48.9% in the 4th quarter. Larson Financial Group LLC now owns 810 shares of the company’s stock valued at $39,000 after purchasing an additional 266 shares during the last quarter. 14.03% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Stock Performance

Shares of Sanofi stock opened at $42.95 on Friday. Sanofi has a one year low of $40.89 and a one year high of $52.68. The company has a market cap of $104.13 billion, a PE ratio of 12.00, a P/E/G ratio of 1.03 and a beta of 0.34. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.22 and a current ratio of 1.01. The business has a 50-day simple moving average of $44.16 and a 200-day simple moving average of $46.04.

Sanofi Increases Dividend

The company also recently declared an annual dividend, which was paid on Wednesday, June 3rd. Investors of record on Monday, May 4th were paid a $2.4225 dividend. This is an increase from Sanofi’s previous annual dividend of $2.04. This represents a yield of 559.0%. The ex-dividend date was Monday, May 4th. Sanofi’s payout ratio is presently 49.16%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on SNY shares. BNP Paribas Exane cut shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 target price on the stock. in a research note on Monday, April 20th. Citigroup reiterated a “neutral” rating on shares of Sanofi in a research report on Monday, April 13th. Weiss Ratings raised shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, May 13th. Morgan Stanley set a $52.00 price target on shares of Sanofi in a research report on Friday, May 1st. Finally, Argus raised shares of Sanofi to a “strong-buy” rating in a research note on Monday, April 27th. Two equities research analysts have rated the stock with a Strong Buy rating, three have assigned a Buy rating and ten have issued a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $51.00.

Sanofi Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.